申请人:Mitsuya Morihiro
公开号:US20060258701A1
公开(公告)日:2006-11-16
The present invention relates to a compound which has a glucokinase-activating effect and is useful as a therapeutic agent for diabetes mellitus, being represented by a formula (I):
[wherein X
1
represents a nitrogen atom, sulfur atom, oxygen atom or the like; R
1
represents a 6- to 10-membered aryl group, 5- to 7-membered heteroaryl group or the like; D represents an oxygen atom or sulfur atom; R and R
3
are the same or different, each representing a hydrogen atom, lower alkyl group or the like; a formula (II)
represents an optionally substituted 5- to 7-membered heteroaryl group or the like; a formula (III)
represents a monocyclic or bicyclic heteroaryl group] or a pharmaceutically acceptable salt thereof.
本发明涉及一种化合物,具有激活葡萄糖激酶的效果,并可用作糖尿病治疗剂,其化学式表示为(I):[其中X1表示氮原子、硫原子、氧原子或类似物;R1表示6-至10-成员芳基基团、5-至7-成员杂芳基基团或类似物;D表示氧原子或硫原子;R和R3相同或不同,分别表示氢原子、低碳基或类似物;式(II)表示可选取代的5-至7-成员杂芳基团或类似物;式(III)表示单环或双环杂芳基团]或其药学上可接受的盐。